Louie Fidaxomicin
2011
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
In 629 patients with Clostridium difficile infection, fidaxomicin reduced recurrence at 4 weeks compared with oral vancomycin with similar clinical cure.
Result
- Absolute difference
- 9.9 points
The absolute difference is derived from the event rates.
Also reported: Cure similar (~88 %); fewer with fidaxomicin in non-NAP1 strains.
- Subtopic
- Initial therapy
- Design
- Double-blind RCT
- Relevance
- Important: one of several pillars.
- Source
- Louie TJ, et al. N Engl J Med. 2011;364(5):422-431.doi 10.1056/NEJMoa0910812
Discussion & critique
Established fidaxomicin as the preferred agent for initial and first-recurrence CDI, now reflected in IDSA/SHEA 2021 guidance.